Journal Logo

Poster Session I: Myeloma and other monoclonal gammopathies – Clinical

PF597 HIGH DOSE MELPHALAN (200MG/M2) AND AUTOLOGOUS TRANSPLANTATION IN NEWLY-DIAGNOSED MULTIPLE MYELOMA UP TO THE AGE OF 70 YEARS: A SUBGROUP ANALYSIS FROM THE PHASE III GMMG-MM5 TRIAL

Mai, E.K.1,2; Miah, K.3; Merz, M.1; Dürig, J.4; Scheid, C.5; Weisel, K.C.6,7; Kunz, C.3; Bertsch, U.1,2; Munder, M.8; Lindemann, H.-W.9; Hose, D.1; Jauch, A.10; Seckinger, A.1; Luntz, S.11; Sauer, S.1; Fuhrmann, S.12; Brossart, P.13; Elmaagacli, A.14; Goerner, M.15; Bernhard, H.16; Hoffmann, M.17; Raab, M.S.1; Blau, I.W.18; Hänel, M.19; Benner, A.3; Salwender, H.J.20; Goldschmidt, H.1,2

Author Information
doi: 10.1097/01.HS9.0000560676.85259.68
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.